in News
Clinical Trials Announced for New Lyme Disease Vaccine
Clinical Trials Announced for New Lyme Disease Vaccine Valneva, a French company focused on developing innovative life-saving vaccines, announced in mid-December that its vaccine candidate VLA15 against Lyme disease has received US Food and Drug Administration (FDA) and European Union Clinical Trial Application (CTA) approval to conduct a Phase I trial in 180 adults in […] More
